FOLH1 and prostate cancer: To target prostate cancer cells, Kim et al. used shRNAs against the gene BCL-xL and the PSMA (prostate-specific membrane antigens) aptamer (A10–3) conjugated to a polyethyleneimine (PEI)-PEG construction.